Title

SGLT2 Inhibitors: Effect of Dapagliflozin in Patients with Type 2 Diabetes who have inadequate Glycemic Control with Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Document Type

Presentation

Presentation Date

2-5-2015

Abstract

Objectives:

  • Review the pathophysiology of DM2 and the pharmacology of oral DM2 agents
  • Review the FDA drug approval process
  • Critically analyze one of the many recent articles on SGLT2 inhibitors
  • Discuss the relevance of this novel class to the care of our patients

Presentation: 28 minutes